DE3841763A1 - Neue tnf-peptide - Google Patents

Neue tnf-peptide

Info

Publication number
DE3841763A1
DE3841763A1 DE3841763A DE3841763A DE3841763A1 DE 3841763 A1 DE3841763 A1 DE 3841763A1 DE 3841763 A DE3841763 A DE 3841763A DE 3841763 A DE3841763 A DE 3841763A DE 3841763 A1 DE3841763 A1 DE 3841763A1
Authority
DE
Germany
Prior art keywords
group
val
peptide
amino
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE3841763A
Other languages
German (de)
English (en)
Inventor
Hans-Joachim Dr Boehm
Lothar Dr Daum
Andreas Dr Haupt
Bernhard Dr Schmied
Nigel Dr Walker
Johann-Christian Dr Zechel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to DE3841763A priority Critical patent/DE3841763A1/de
Priority to JP2500557A priority patent/JPH04502309A/ja
Priority to EP90900107A priority patent/EP0447430A1/fr
Priority to PCT/EP1989/001475 priority patent/WO1990006947A1/fr
Priority to CA002005050A priority patent/CA2005050A1/fr
Publication of DE3841763A1 publication Critical patent/DE3841763A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3841763A 1988-12-12 1988-12-12 Neue tnf-peptide Withdrawn DE3841763A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE3841763A DE3841763A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide
JP2500557A JPH04502309A (ja) 1988-12-12 1989-12-02 新規ｔｎｆ―ペプチド
EP90900107A EP0447430A1 (fr) 1988-12-12 1989-12-02 Nouveaux peptides derives du facteur de necrose de tumeurs (tnf)
PCT/EP1989/001475 WO1990006947A1 (fr) 1988-12-12 1989-12-02 Nouveaux peptides derives du facteur de necrose de tumeurs (tnf)
CA002005050A CA2005050A1 (fr) 1988-12-12 1989-12-11 Peptides tnf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3841763A DE3841763A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Publications (1)

Publication Number Publication Date
DE3841763A1 true DE3841763A1 (de) 1990-06-13

Family

ID=6368958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3841763A Withdrawn DE3841763A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Country Status (5)

Country Link
EP (1) EP0447430A1 (fr)
JP (1) JPH04502309A (fr)
CA (1) CA2005050A1 (fr)
DE (1) DE3841763A1 (fr)
WO (1) WO1990006947A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4340111A1 (de) * 1993-11-22 1995-05-24 Schering Ag Tumor-Nekrose-Faktor-alpha inaktivierende Peptide
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5827821A (en) * 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
US5880092A (en) * 1987-12-10 1999-03-09 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US6013625A (en) * 1990-04-06 2000-01-11 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US7173110B2 (en) * 2004-11-08 2007-02-06 New York University Peptide anti-tumor agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5245290A (en) * 1975-10-08 1977-04-09 Hitachi Ltd Integrated circuit of semiconductor and method for its fabrication
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
EP0110791B1 (fr) * 1982-11-30 1990-04-25 Institut Pasteur Peptides comportant un site immunogène du poliovirus et ADNs contenant des séquences nucléotidiques codant pour ces peptides
US4518527A (en) * 1983-08-16 1985-05-21 Mitsubishi Chemical Industries Limited Polypeptides related to the pre-acetylcholine receptor-α of the electric organ of Torpedo californica
JPS60160125A (ja) * 1984-01-30 1985-08-21 Mitsubishi Electric Corp 半導体装置の製造方法
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US4556585A (en) * 1985-01-28 1985-12-03 International Business Machines Corporation Vertically isolated complementary transistors
JPS6231153A (ja) * 1985-08-02 1987-02-10 Matsushita Electric Ind Co Ltd Ｍｉｓ型半導体集積回路の製造方法
JPS6296390A (ja) * 1985-10-21 1987-05-02 Nec Corp 気相エピタキシヤル成長法
EP0247906B1 (fr) * 1986-02-04 1994-12-28 Mizuno, Den'Ichi ADN codant pour des polypeptides antitumoraux, les polypeptides et les agents antitumoraux contenant ces polypeptides

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985827A (en) * 1987-12-10 1999-11-16 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US6020460A (en) * 1987-12-10 2000-02-01 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US7030213B2 (en) 1987-12-10 2006-04-18 La Jolla Cancer Research Institute Conformationally stabilized cell adhesion peptides
US6353090B1 (en) 1987-12-10 2002-03-05 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5981468A (en) * 1987-12-10 1999-11-09 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5880092A (en) * 1987-12-10 1999-03-09 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5827821A (en) * 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
US5906975A (en) * 1987-12-10 1999-05-25 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6013625A (en) * 1990-04-06 2000-01-11 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6100236A (en) * 1990-04-06 2000-08-08 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6395873B1 (en) 1990-04-06 2002-05-28 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
DE4340111A1 (de) * 1993-11-22 1995-05-24 Schering Ag Tumor-Nekrose-Faktor-alpha inaktivierende Peptide

Also Published As

Publication number Publication date
JPH04502309A (ja) 1992-04-23
CA2005050A1 (fr) 1990-06-12
WO1990006947A1 (fr) 1990-06-28
EP0447430A1 (fr) 1991-09-25

Similar Documents

Publication Publication Date Title
DE69329425T2 (de) Dolastatin analog
DE3841753A1 (de) Neue tnf-peptide
DE69320339T2 (de) Derivate des Dolastatin
DE3841759A1 (de) Neue tnf-peptide
DE3841763A1 (de) Neue tnf-peptide
DE3841768A1 (de) Neue tnf-peptide
DE69029377T2 (de) Substituierungsanaloge von magaininpeptiden
DE3939797A1 (de) Neue vom neuropeptid y abgeleitete peptide
DE3841761A1 (de) Neue tnf-peptide
DE3841762A1 (de) Neue tnf-peptide
DE3841767A1 (de) Neue tnf-peptide
DE3841764A1 (de) Neue tnf-peptide
DE3841754A1 (de) Neue tnf-peptide
DE3841755A1 (de) Neue tnf-peptide
DE4041188A1 (de) Neue tnf-peptide
DE4041187A1 (de) Neue tnf-peptide
DE4041189A1 (de) Neue-tnf-peptide
EP0570375A1 (fr) Nouveaux peptides a activite anticoagulante.
DE1668875A1 (de) Neue Peptide mit ACTH-Wirkung

Legal Events

Date Code Title Description
8130 Withdrawal